| | | | | | | | | | |
|
|
| Dockets Entered
On January 20, 2004
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| 1999P-5332
|
| Amend limit Hydrogenated & partially Hydrogenated Menhaden O
|
|
|
| 2000D-1598
|
| Voluntary Labeling for Bioengineered Foods
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
| 2001P-0345
|
| Listing the color additive yellow #5 for use in food/Drug
|
|
|
| 2002D-0094
|
| IND Exemptions for Studies of Lawfully Marketed Cancer Drugs
|
|
|
| 2002N-0058
|
| Pediculicide Drug Products for OTC Human Use
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
| 2003D-0380
|
| Draft Guidance for Industry: PAT - A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance; Availability
|
|
|
| 2003D-0558
|
| Guidance Levels for Radionuclides in Domestic and Imported Foods
|
|
|
| 2004V-0029
|
| Laser Light Show
|
|
|
| 2004V-0030
|
| Projector for a Laser Light Show
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| LET
12296
|
| Jarrow Formulas
|
| Vol #:
|
| 99
|
|
|
| LET
12297
|
| Jarrow Formulas
|
| Vol #:
|
| 99
|
|
|
| LET
12298
|
| Jarrow Formulas
|
| Vol #:
|
| 99
|
|
|
| LET
12299
|
| Jarrow Formulas
|
| Vol #:
|
| 99
|
|
|
| LET
12300
|
| Jarrow Formulas
|
| Vol #:
|
| 99
|
|
|
| LET
12301
|
| Jarrow Formulas
|
| Vol #:
|
| 99
|
|
|
| LET
12302
|
| Jarrow Formulas
|
| Vol #:
|
| 99
|
|
|
| LET
12303
|
| Jarrow Formulas
|
| Vol #:
|
| 99
|
|
|
| LET
12304
|
| Jarrow Formulas
|
| Vol #:
|
| 99
|
|
|
| 1999P-5332
|
| Amend limit Hydrogenated & partially Hydrogenated Menhaden O
|
|
|
| BKG 2
|
| Background Information Refs 1 - 3
|
| Vol #:
|
| 2
|
|
|
| NTF
1
|
| FDA
|
| Vol #:
|
| 2
|
|
|
| 2000D-1598
|
| Voluntary Labeling for Bioengineered Foods
|
|
|
| EMC 12016
|
| N. Watson-Jones
|
| Vol #:
|
| 574
|
|
|
| 2001P-0075
|
| Switch Status of Emergency Contraceptives from Rx to OTC
|
|
|
| EMC 2821
|
| F. Davidoff
|
| Vol #:
|
| 130
|
|
|
| EMC 2822
|
| M.I. Fowler,MS,RN
|
| Vol #:
|
| 130
|
|
|
| EMC 2823
|
| D. Grass
|
| Vol #:
|
| 130
|
|
|
| EMC 2824
|
| H. D. McGinley
|
| Vol #:
|
| 130
|
|
|
| EMC 2825
|
| H. McGinleys
|
| Vol #:
|
| 130
|
|
| | | | | | | | |
|
|
| EMC 2826
|
| P.F. Timmerman
|
| Vol #:
|
| 130
|
|
|
| EMC 2827
|
| M. Edwards
|
| Vol #:
|
| 130
|
|
|
| 2001P-0345
|
| Listing the color additive yellow #5 for use in food/Drug
|
|
|
| EMC 1214
|
| C. W. McGill
|
| Vol #:
|
| 5
|
|
|
| 2002D-0094
|
| IND Exemptions for Studies of Lawfully Marketed Cancer Drugs
|
|
|
| GDL 3
|
| Guidance
|
| Vol #:
|
| 1
|
|
|
| 2002N-0058
|
| Pediculicide Drug Products for OTC Human Use
|
|
|
| EMC 1
|
| W. Newton
|
| Vol #:
|
| 1
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
| EMC 300
|
| Dr. B. Martini
|
| Vol #:
|
| 5
|
|
|
| EMC 301
|
| Dr. B. Martini
|
| Vol #:
|
| 5
|
|
|
| 2003D-0380
|
| Draft Guidance for Industry: PAT - A Framework for Innovative Pharmaceutical Manufacturing and Quality Assurance; Availability
|
|
|
| EMC
11
Attachment
|
| Facility Automation
Management Engineering Systems
|
| Vol #:
|
| 1
|
|
|
| 2003D-0558
|
| Guidance Levels for Radionuclides in Domestic and Imported Foods
|
|
| BKG
1
|
| Supporting Document for Guidance Levels for Radionuclides in Domestic and Imported Foods
|
| Vol #:
|
| 1
|
|
|
| GDL
1
|
| Guideline
|
| Vol #:
|
| 1
|
|
|
| NAD
1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2004V-0029
|
| Laser Light Show
|
|
|
| ACK
1
|
| HFA-305 to Club LA vela
|
| Vol #:
|
| 1
|
|
|
| VAR
1
|
| Club LA Vela
|
| Vol #:
|
| 1
|
|
|
| 2004V-0030
|
| Projector for a Laser Light Show
|
|
|
| ACK
1
|
| HFA-305 to HB Stereo Inc.
|
| Vol #:
|
| 1
|
|
|
| ACK 2
|
| Number not used
|
| Vol #:
|
| 1
|
|
|
| VAR
1
|
| HB Stereo Inc.
|
| Vol #:
|
| 1
|
|